NFKB1 and cancer: To develop a strategy for inhibiting the NF-κB pathway in a cancer-selective manner and, thus, exploiting its therapeutic potential, we therefore sought to delineate the mechanism(s) underlying the pathological survival activity of constitutive NF-κB signaling in MM.